Linear IgA disease: successful treatment with cyclosporin.
Young
H S
HS
Coulson
I H
IH
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D016572:Cyclosporine / Q000627:therapeutic use*; D003622:Dapsone / Q000009:adverse effects; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003879:Dermatologic Agents; D007070:Immunoglobulin A; D016572:Cyclosporine; D003622:Dapsone; D011239:Prednisolone